相关实验视频
Updated: May 5, 2026

07:56
Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
Published on: August 18, 2010
13.5K
长期瘤向效应的E. 大肠杆菌作为一种药物输送系统
Gun Gyun Kim1, Hongje Lee1, Dan Bi Jeong1,2
1Department of Nuclear Medicine, Dongnam Institute of Radiological and Medical Sciences, Busan 46033, Republic of Korea.
Pharmaceuticals (Basel, Switzerland)
|April 27, 2024
概括
工程Escherichia coli (大肠杆菌) 细菌有效地向瘤提供药物. 这种新型系统使用-89 (89Zr) PET成像证明了长期稳定性和生物分布跟踪.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 医疗成像医学成像
背景情况:
- 当前的纳米/微尺度药物输送系统面临着局限性.
- 大肠杆菌 (E. coli) 为药物输送提供了一个潜在的替代方案.
- 瘤向需要有效的策略,例如与细胞膜蛋白质的化学结合.
研究的目的:
- 开发一种基于大肠杆菌的药物输送系统,以有效向瘤.
- 评估大肠杆菌系统的长期生物分布和瘤积累.
- 评估标记在大肠杆菌表面的放射性同位素的体内稳定性.
主要方法:
- 膜蛋白通过初级氨基基团与大肠杆菌的化学结合.
- 使用 DFO 酸盐,用-89 (89Zr) 标记膜蛋白.
- 在体内使用正子发射断层扫描 (PET) 成像的长期生物分布研究.
- 评估89Zr标记的大肠杆菌在时间上的稳定性.
主要成果:
- 大肠杆菌在静脉注射后5分钟内迅速在瘤中积累.
- 在注射后6天内,在瘤中观察到高水平的大肠杆菌.
- 与大肠杆菌表面蛋白结合的-89 (89Zr) 在体内表现出长期稳定性.
结论:
- 基于大肠杆菌的系统显示出作为瘤向药物输送载体的巨大潜力.
- 开发的系统表现出有利的长期生物分布和瘤积累.
- 大肠杆菌表面的放射性同位素标记在体内长时间保持稳定,使得有效的跟踪.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160

